Clinical trial readiness through the establishment of a pilot filovirus investigational vaccine reserve

Summary

The tender concerns research and experimental development services to improve clinical trial readiness for Filovirus outbreaks. The contractor must establish, pilot and maintain an EU-based reserve of investigational vaccine candidates for Ebola Sudan (SUDV), Ebola Bundibugyo (BDBV) and/or Marburg (MARV), and ensure rapid deployment of investigational doses if an outbreak occurs and the contracting authority gives consent. The notice does not provide precise qualification or exclusion requirements; these must be checked in the official tender documents.